INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $137,000 | -74.2% | 120,097 | -49.1% | 0.04% | -73.1% |
| Q4 2021 | $531,000 | -34.3% | 236,160 | 0.0% | 0.13% | -37.4% |
| Q3 2021 | $808,000 | -41.2% | 236,160 | -48.6% | 0.21% | -25.4% |
| Q2 2021 | $1,373,000 | -7.4% | 459,260 | 0.0% | 0.29% | -18.5% |
| Q1 2021 | $1,483,000 | – | 459,260 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,766,508 | $19,826,000 | 2.39% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,286,032 | $2,610,000 | 0.07% |
| Clear Harbor Asset Management, LLC | 153,800 | $312,000 | 0.06% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 219,652 | $445,000 | 0.03% |
| Rock Springs Capital Management LP | 270,000 | $548,000 | 0.02% |
| Alambic Investment Management, L.P. | 77,665 | $158,000 | 0.02% |
| Marshall Wace North America L.P. | 1,173,515 | $2,382,000 | 0.01% |
| Baker Brothers Advisors | 580,400 | $1,178,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $932,000 | 0.01% |
| Intellectus Partners, LLC | 13,000 | $26,000 | 0.01% |